Literature DB >> 5426213

[2 patients with congenital factor XIII deficiency. Contribution to the problem of factor XIII determination].

R Egbring, K Andrassy, H Egli, J Meyer-Lindenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5426213

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN： 0340-5338


× No keyword cloud information.
  8 in total

1.  Type I and type II disease in congenital factor XIII deficiency. A further demonstration of the correctness of the classification.

Authors:  A Girolami; M G Cappellato; A R Lazzaro; M Boscaro
Journal:  Blut       Date:  1986-11

2.  [Molecular structure of fibrin stabilizing factors in man. II. Comparative immunologic studies on factor XIII deficient plasma and normal plasma].

Authors:  H Bohn; W Becker; H Trobisch
Journal:  Blut       Date:  1973-05

3.  [Behaviour of factor XIII in normal children and in various diseases in childhood].

Authors:  W Rath; J Ströder
Journal:  Klin Wochenschr       Date:  1972-03-01

4.  [Diagnostic and therapeutic problems in congenital afibrinogenemia].

Authors:  R Egbring; K Andrassy; H Egli; J Meyer-Lindenberg
Journal:  Blut       Date:  1971-04

5.  [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].

Authors:  R Egbring; K Andrassy; K Havemann; G Fuchs; B Ruf; K Schander; H Trobisch
Journal:  Blut       Date:  1976-12

6.  Immunological studies of coagulation factor XIII.

Authors:  E D Israels; F Paraskevas; L G Israels
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

7.  [Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)].

Authors:  R Zimmermann; W Ehlers; F Manz; W Meinrenken; R Egbring; H Gemmeke
Journal:  Blut       Date:  1977-12

8.  Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiency.

Authors:  J J Pisano; J S Finlayson; M P Peyton; Y Nagai
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.